Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Shawn, Ibna Hasan
مؤلفون آخرون:	Jamiruddin, Mohd. Raeed
التنسيق:	أطروحة
اللغة:	English
منشور في:	Brac University 2024
الموضوعات:	RCC Demographic analysis Pazopanib Nivolumab plus Ipilimumab Progression-free survival Serious adverse events Overall adverse events Kidneys > Cancer > Molecular aspects. Renal cell carcinoma.
الوصول للمادة أونلاين:	http://hdl.handle.net/10361/23931

الوصف
الملخص:	This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

مواد مشابهة